In Compton Lecture at MIT, social psychologist Jonathan Haidt warns of dramatic global decay in cognition, attention spans, and civic life, and urges curbs to tech use.

The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.

Assistant Professor Alison Ringel will investigate the intersection of immunology and aging biology, aiming to define mechanisms that underlie aging-related decline, thanks to a grant from the foundation.

By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.

Researchers find mice modeling the autism spectrum disorder fragile X syndrome exhibit the same pattern of differences in low-frequency waves as humans — a new marker for treatment studies.

In STS.059 (The Bioeconomy and Society), students explore the social and political factors at work in the biology, biotech, and biological engineering sectors.

Driven by overuse and misuse of antibiotics, drug-resistant infections are on the rise, while development of new antibacterial tools has slowed.

Opening a new window on the brainstem, a new tool reliably and finely resolves distinct nerve bundles in live diffusion MRI scans, revealing signs of injury or disease.

MagMix, an onboard mixing device, enables scalable manufacturing of 3D-printed tissues.

Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.

Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.

WITEC is working to develop the first wearable ultrasound imaging system to monitor chronic conditions in real-time, with the goal of enabling earlier detection and timely intervention.

The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.

The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.

Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.

Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.

Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.

Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.

Professor, mentor, and leader at MIT for more than 50 years shaped fundamental understandings of cell adhesion, the extracellular matrix, and molecular mechanisms of metastasis.

New research detects hidden evidence of mistaken correlations — and provides a method to improve accuracy.

MIT engineers designed capsules with biodegradable radio frequency antennas that can reveal when the pill has been swallowed.

Time and again, an unassuming roundworm has illuminated aspects of biology with major consequences for human health.

Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.

Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.

The MIT senior helps design proteins that spur the immune system to fight cancer and other diseases.

New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.

MIT community members made headlines with key research advances and their efforts to tackle pressing challenges.

New research suggests liver cells exposed to too much fat revert to an immature state that is more susceptible to cancer-causing mutations.

New research suggests liver cells exposed to too much fat revert to an immature state that is more susceptible to cancer-causing mutations.

Global Change Outlook report for 2025 shows how accelerated action can reduce climate risks and improve sustainability outcomes, while highlighting potential geopolitical hurdles.

The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.

Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.

A study profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking a treatment-resistant and deadly brain cancer.

Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.

Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.

Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.

Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival.

Preliminary studies find derivatives of the compound, known as verticillin A, can kill some types of glioma cells.

The approach could transform large-scale biomanufacturing by enabling automated and contamination-conscious workflows for cell therapies, tissue engineering, and regenerative medicine.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.

An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.

A new study identifies genetic modifications that make these immune cells, known as CAR-NK cells, more effective at destroying cancer cells.

The findings may offer a new way to help heal tissue damage from radiation or chemotherapy treatment.

Chemotherapy-induced injury of organ tissue causes inflammation that awakens dormant cancer cells, which may cause new tumors to form.

Outfitted with antibodies that guide them to the tumor site, the new nanoparticles could reduce the side effects of treatment.

Researchers developed a tool to recreate cells’ family trees. Comparing cells’ lineages and locations within a tumor provided insights into factors shaping tumor growth.

CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.

Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.

Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.